Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence
about
High-grade glioma management and response assessment-recent advances and current challengesA state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-AnalysisMR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis.MR-guided radiation therapy: transformative technology and its role in the central nervous system.Quantitative MRI for analysis of peritumoral edema in malignant gliomasOsseous Pseudoprogression in Vertebral Bodies Treated with Stereotactic Radiosurgery: A Secondary Analysis of Prospective Phase I/II Clinical Trials.Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients.Vascular Reactivity Maps in Patients with Gliomas Using Breath-Holding BOLD fMRI.Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma paAmino acid PET and MR perfusion imaging in brain tumours.Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.A Simple Automated Method for Detecting Recurrence in High-Grade Glioma.Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.Molecular and histologic characteristics of pseudoprogression in diffuse gliomas.The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.Apparent transverse relaxation (R2∗) on MRI as a method to differentiate treatment effect (pseudoprogression) versus progressive disease in chemoradiation for malignant glioma.Increased signal intensity within glioblastoma resection cavities on fluid-attenuated inversion recovery imaging to detect early progressive disease in patients receiving radiotherapy with concomitant temozolomide therapy.Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study.Diffusion Weighted/Tensor Imaging, Functional MRI and Perfusion Weighted Imaging in Glioblastoma-Foundations and Future.Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.Brain gliomas: reporting essentials and treatment response.Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in GlioblastomaJoint approach of diffusion- and perfusion-weighted MRI in intra-axial mass like lesions in clinical practice simulation
P2860
Q26740664-309169B0-0CE2-41FA-9B85-5C127D41CCBAQ31130812-9C0D98F4-05D0-44DE-A040-3C47C10A3EE0Q31153877-8E1529BC-E658-4CE2-8E35-F59585701B11Q35771783-902B72CD-B7E7-4DB4-BDCC-E8FF2424D17EQ35888150-23D10395-DCE3-44ED-8B92-3B6325D8F27BQ36097886-AABF75F3-1542-44F8-B22F-7ED78BF66127Q36308850-90388FC5-9D1E-4119-9849-37394ACE25BFQ36336361-2A6547C1-828E-4A49-962B-4C52F003D782Q36380888-8F447405-D339-4121-A387-BD6DCB2366D1Q36578186-7C0429D0-3965-49A0-B0EF-9EB6C7561277Q36785131-7D16F6B0-DDB6-4E4D-8D3E-66E0552A07F5Q37380167-FD80A6F1-29EE-44F7-ADC0-E2A0D7DCA659Q37746319-3D1F9C19-9DA2-4733-AAB3-BE5C090C8216Q38691946-8BC505B1-0603-4AAB-A575-1DA56EC7A4ADQ38814458-350454FD-5612-4ACF-8D64-79584ACFB9EAQ39030177-F5CC8EB7-9852-4437-AE6A-7C59710AD116Q39600093-02A1AC95-E72A-4C15-A84F-FEAB5AF02C5EQ39765594-BE01AF82-2FEE-408A-867E-0EC40A50EFB2Q43376098-C3F284A8-4643-49A3-A016-D2BA9A82E4A3Q47101710-7E2516FC-F470-4174-AD1A-F849BD64DB73Q47281917-0BB5295C-E12F-4E8C-A05F-307F788C72C0Q47385832-1EABAD17-A774-4E4F-8167-61B7FE24C0FFQ47619745-C4D7FBAE-B81D-4D51-B4C1-7825863D37AAQ48246048-2BF48712-40D3-46DD-8C90-61A4BE5379F1Q49274965-C310A10F-B998-488C-95AC-87FC348BF8F3Q52091021-DE63A59D-6F57-4E04-84DE-2F889691680AQ55205597-3A92E4B1-90FD-472E-A611-640AADB880A6Q58730832-C06B8934-0B87-406C-8CC6-E32D400CFF2BQ58760144-C7A5D3CF-7DB0-42EC-8BAC-FC5DA068E54B
P2860
Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Diffusion and perfusion MRI to ...... with histopathologic evidence
@ast
Diffusion and perfusion MRI to ...... with histopathologic evidence
@en
type
label
Diffusion and perfusion MRI to ...... with histopathologic evidence
@ast
Diffusion and perfusion MRI to ...... with histopathologic evidence
@en
prefLabel
Diffusion and perfusion MRI to ...... with histopathologic evidence
@ast
Diffusion and perfusion MRI to ...... with histopathologic evidence
@en
P2093
P2860
P50
P356
P1476
Diffusion and perfusion MRI to ...... with histopathologic evidence
@en
P2093
P2860
P304
P356
10.3174/AJNR.A4218
P577
2015-01-15T00:00:00Z